Cargando…
Abaloparatide Increases Lumbar Spine and Hip BMD in Japanese Patients With Osteoporosis: The Phase 3 ACTIVE-J Study
CONTEXT: Abaloparatide reduced fracture risk in postmenopausal women with osteoporosis in the Abaloparatide Comparator Trial In Vertebral Endpoints (ACTIVE). Its effect in Japanese patients remains unexamined. OBJECTIVE: This work aimed to determine the efficacy and safety of abaloparatide in increa...
Autores principales: | Matsumoto, Toshio, Sone, Teruki, Soen, Satoshi, Tanaka, Sakae, Yamashita, Akiko, Inoue, Tetsuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516124/ https://www.ncbi.nlm.nih.gov/pubmed/35977548 http://dx.doi.org/10.1210/clinem/dgac486 |
Ejemplares similares
-
The effects of abaloparatide on hip geometry and biomechanical properties in Japanese osteoporotic patients assessed using DXA-based hip structural analysis: results of the Japanese phase 3 ACTIVE-J trial
por: Sone, Teruki, et al.
Publicado: (2023) -
ERRATUM for “Effect of Abaloparatide vs Alendronate on Fracture Risk Reduction in Postmenopausal Women With Osteoporosis”
Publicado: (2020) -
Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE
por: Eastell, R., et al.
Publicado: (2019) -
Concordane of OSTA and lumbar spine BMD by DXA in identifying risk of osteoporosis
por: Lu, ChunYan, et al.
Publicado: (2006) -
BMD-Related Genetic Risk Scores Predict Site-Specific Fractures as Well as Trabecular and Cortical Bone Microstructure
por: Nethander, Maria, et al.
Publicado: (2020)